A Phase 2/3, Randomized, 3-Part Study to Investigate the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients with Eosinophilic Gastritis with or without Eosinophilic Duodenitis
Ages of participants: Adults and adolescents
Type of Study: Interventional
Location: US, Canada, Japan, Australia, Italy, Poland, and France
Learn more: Welcome to Engage Clinical Study
Clinicaltrials.gov identifier: NCT05831176
PilOt Assessment to Find Evidence of Gastric Motility Abnormalities in Eosinophilic Gastric Disorders (OAT-FEED)
Ages: 18-59
Study Type: Observational
Location: Multiple locations in U.S.
Learn More
A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Efficacy of Dupilumab (ANTI-IL4RA) in Subjects with Eosinophilic Gastritis
Ages: 12-71
Study Type: Interventional
Location: Multiple locations in U.S.
Learn more
DEGAS Recruitment Brochure
OMEGA-A Prospective, Multicenter Study to Compare and Validate Endoscopic, Histologic, Molecular and Patient-Reported Outcomes in Pediatric and Adult Patients with Eosinophilic Esophagitis (EoE), Gastritis (EG), Gastroenteritis (EGE) and Colitis (EC)
Ages: 3-65
Study Reference:NCT02523118
Study Type: Observational
Location: Multiple locations in U.S.
Learn more
OMEGA Advertisement Flyer pdf
Download the flyer
Data and Sample Collection Study to Elucidate the Mechanisms of Eosinophilic Disorders
Ages: consent obtained for ages 11+
Study Reference: NCT00267501
Study type: Observational
Location: Cincinnati, OH
Learn more
